Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Integra Lifesciences Holdings (IART) Prepaid Assets (2016 - 2025)

Integra Lifesciences Holdings (IART) has disclosed Prepaid Assets for 17 consecutive years, with $96.1 million as the latest value for Q4 2025.

  • Quarterly Prepaid Assets rose 24.79% to $96.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $96.1 million through Dec 2025, up 24.79% year-over-year, with the annual reading at $96.1 million for FY2025, 24.79% up from the prior year.
  • Prepaid Assets hit $96.1 million in Q4 2025 for Integra Lifesciences Holdings, up from $94.1 million in the prior quarter.
  • In the past five years, Prepaid Assets ranged from a high of $131.0 million in Q3 2023 to a low of $28.8 million in Q2 2024.
  • Historically, Prepaid Assets has averaged $84.6 million across 5 years, with a median of $87.6 million in 2021.
  • Biggest five-year swings in Prepaid Assets: soared 117.07% in 2023 and later tumbled 77.7% in 2024.
  • Year by year, Prepaid Assets stood at $91.1 million in 2021, then crashed by 65.92% to $31.0 million in 2022, then surged by 117.07% to $67.4 million in 2023, then increased by 14.31% to $77.0 million in 2024, then increased by 24.79% to $96.1 million in 2025.
  • Business Quant data shows Prepaid Assets for IART at $96.1 million in Q4 2025, $94.1 million in Q3 2025, and $36.1 million in Q2 2025.